Chang, Stella

Ring, Brian Z

Ring, L Winston

Ross, Douglas T

Seitz, Robert S

BMC Genomics

English

PubMed

Springer - Publisher Connector

Gene expression patterns within cell lines are predictive of chemosensitivity

Brian Z Ring

Stella Chang

L Winston Ring

Robert S Seitz

Douglas T Ross

Crossref

A direct approach to false discovery rates.

A gene expression database for the molecular pharmacology of cancer.

Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov

Controlling the false discovery rate: A practical and powerful approach to multiple testing.

Developmental Theraputics Program [http://dtp.nci.nih.gov/ mtargets/download.html].

DG: Establishing connections between microarray expression data and chemotherapeutic cancer pharmacology. Mol Cancer Ther

Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.

Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell

Huang S: Comparison of false discovery rate methods in identifying genes with differential expression. Genomics

Isaksson A: Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles.

JR: Genomic signatures to guide the use of chemotherapeutics. Nat Med

KD: An information-intensive approach to the molecular pharmacology of cancer. Science

Kudoh S: Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database.

MR: New colorimetric cytotoxicity assay for anticancer-drug screening.

Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. Cancer Res

Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data. Pharmacogenomics J

PO: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet

Power and type I error rate of false discovery rate approaches in genomewide association studies.

Predicting cancer drug response by proteomic profiling. Clin Cancer Res

Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival. Oncogene

SE: Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns.

Singular value decomposition for genome-wide expression data processing and modeling.

The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer

Tibshirani R: Statistical significance for genomewide studies.

TR: Chemosensitivity prediction by transcriptional profiling.

TR: Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell

TR: The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science

Why is cancer drug discovery so difficult? Nat Rev Drug Discov

XJ: Linking tumor cell cytotoxicity to mechanism of drug action: an integrated analysis of gene expression, small-molecule screening and structural databases. Proteins

Yamori T: Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays. Mol Cancer Ther

https://bmcgenomics.biomedcentral.com/track/pdf/10.1186/1471-2164-9-74?site=bmcgenomics.biomedcentral.com

Gene expression patterns within cell lines are predictive of chemosensitivity

Abstract

Similar works

Full text

Available Versions

Springer - Publisher Connector

Crossref